Shuang Feng Selected Research

Glioma (Gliomas)

1/2020	USP18 deubiquitinates and stabilizes Twist1 to promote epithelial-mesenchymal transition in glioblastoma cells.
1/2020	A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
1/2019	Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma.
12/2011	Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells.
9/2011	RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuang Feng Research Topics

Disease

22	Neoplasms (Cancer) 10/2023 - 05/2010
9	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2016
8	Inflammation (Inflammations) 01/2020 - 10/2014
7	Thrombosis (Thrombus) 12/2023 - 01/2016
5	Carcinogenesis 01/2023 - 02/2011
5	Glioma (Gliomas) 01/2020 - 09/2011
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2019
4	Obesity 07/2019 - 01/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 03/2012
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2023 - 01/2013
3	Hematoma 01/2023 - 01/2022
3	Liver Neoplasms (Liver Cancer) 09/2022 - 09/2019
3	Pneumonia (Pneumonitis) 01/2021 - 09/2016
3	Asthma (Bronchial Asthma) 01/2020 - 09/2016
3	Infections 01/2020 - 06/2013
3	Atherosclerosis 11/2017 - 01/2016
2	Carcinoma (Carcinomatosis) 10/2023 - 02/2011
2	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2020
2	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2010
2	Hemorrhage 01/2022 - 11/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 10/2013
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2018
2	autosomal recessive 1 Spinocerebellar ataxia 01/2021 - 10/2013
2	Pain (Aches) 07/2020 - 01/2015
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2018
2	Endometritis 01/2019 - 01/2018
1	Disease Resistance 01/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Genomic Instability 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Disease Progression 12/2022
1	Cerebral Hemorrhage 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	Pneumococcal Infections 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
4	Bevacizumab (Avastin)FDA Link 05/2023 - 09/2022
4	atezolizumabIBA 05/2023 - 09/2022
4	Pattern Recognition ReceptorsIBA 03/2023 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
3	Therapeutic UsesIBA 12/2022 - 01/2021
3	EnzymesIBA 01/2022 - 11/2017
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2013
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2011
3	CytokinesIBA 01/2020 - 03/2017
2	LipopolysaccharidesIBA 03/2023 - 01/2018
2	Lipoproteins (Lipoprotein)IBA 03/2023 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 10/2022 - 11/2021
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 11/2021 - 09/2016
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2021 - 09/2016
2	Conjugate VaccinesIBA 01/2021 - 01/2021
2	Ubiquitin-Specific ProteasesIBA 01/2020 - 10/2019
2	Dinoprostone (PGE2)FDA Link 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2018
2	AntibodiesIBA 01/2019 - 01/2016
2	Estrogen Receptor alphaIBA 01/2018 - 05/2010
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 09/2016
2	Cysteine (L-Cysteine)FDA Link 12/2011 - 09/2011
2	Caveolin 1IBA 02/2011 - 05/2010
1	Membrane LipidsIBA 01/2024
1	Caspase 3 (Caspase-3)IBA 10/2023
1	erucylphosphocholineIBA 10/2023
1	CalciumIBA 10/2023
1	rhod-2IBA 10/2023
1	Fluo 4IBA 10/2023
1	Annexin A5IBA 10/2023
1	Gemcitabine FDA Link 05/2023
1	Cisplatin (Platino)FDA LinkGeneric 05/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2023
1	thiamine triphosphorate (TTP)IBA 01/2023
1	Amyloidogenic ProteinsIBA 01/2023
1	PhosphoproteinsIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Actins (F Actin)IBA 01/2023
1	endostar proteinIBA 10/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	IodidesIBA 11/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2021
1	Coloring Agents (Dyes)IBA 11/2021
1	SilverIBA 03/2021
1	Flap EndonucleasesIBA 03/2021
1	ChromatinIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021

Therapy/Procedure

6	Therapeutics 10/2022 - 09/2011
4	Radiotherapy 10/2023 - 10/2021
3	Microbubbles 12/2023 - 11/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 05/2023 - 11/2021
2	Aftercare (After-Treatment) 10/2022 - 07/2020
2	Immunotherapy 01/2019 - 01/2019
2	Hepatectomy 01/2019 - 01/2016
1	Image-Guided Radiotherapy 10/2023
1	Plastic Surgery Procedures 01/2023